These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27883239)

  • 1. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
    Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
    Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individually dosed omalizumab facilitates peanut oral immunotherapy in peanut allergic adolescents.
    Brandström J; Vetander M; Sundqvist AC; Lilja G; Johansson SGO; Melén E; Sverremark-Ekström E; Nopp A; Nilsson C
    Clin Exp Allergy; 2019 Oct; 49(10):1328-1341. PubMed ID: 31329313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophil allergen threshold sensitivity, CD-sens, IgE-sensitization and DBPCFC in peanut-sensitized children.
    Glaumann S; Nopp A; Johansson SG; Rudengren M; Borres MP; Nilsson C
    Allergy; 2012 Feb; 67(2):242-7. PubMed ID: 22126416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF; Du Toit G; Douiri A; Radulovic S; Stephens A; Turcanu V; Lack G
    J Allergy Clin Immunol; 2015 Jan; 135(1):179-86. PubMed ID: 25567046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relevance of basophil allergen sensitivity testing to distinguish between severe and mild peanut-allergic children.
    Homšak M; Silar M; Berce V; Tomazin M; Skerbinjek-Kavalar M; Celesnik N; Košnik M; Korošec P
    Int Arch Allergy Immunol; 2013; 162(4):310-7. PubMed ID: 24193167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical follow-up of omalizumab in routine treatment of allergic asthma monitored by CD-sens.
    Johansson SGO; Lilja G; Hallberg J; Nopp A
    Immun Inflamm Dis; 2018 Sep; 6(3):382-391. PubMed ID: 29737044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.
    Savage JH; Courneya JP; Sterba PM; Macglashan DW; Saini SS; Wood RA
    J Allergy Clin Immunol; 2012 Nov; 130(5):1123-1129.e2. PubMed ID: 22800401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab facilitates rapid oral desensitization for peanut allergy.
    MacGinnitie AJ; Rachid R; Gragg H; Little SV; Lakin P; Cianferoni A; Heimall J; Makhija M; Robison R; Chinthrajah RS; Lee J; Lebovidge J; Dominguez T; Rooney C; Lewis MO; Koss J; Burke-Roberts E; Chin K; Logvinenko T; Pongracic JA; Umetsu DT; Spergel J; Nadeau KC; Schneider LC
    J Allergy Clin Immunol; 2017 Mar; 139(3):873-881.e8. PubMed ID: 27609658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining analyses of basophil allergen threshold sensitivity, CD-sens, and IgE antibodies to hydrolyzed wheat, ω-5 gliadin and timothy grass enhances the prediction of wheat challenge outcome.
    Nilsson N; Nilsson C; Hedlin G; Johansson SG; Borres MP; Nopp A
    Int Arch Allergy Immunol; 2013; 162(1):50-7. PubMed ID: 23816701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation.
    Nopp A; Johansson SG; Ankerst J; Bylin G; Cardell LO; Grönneberg R; Irander K; Palmqvist M; Oman H
    Allergy; 2006 Mar; 61(3):298-302. PubMed ID: 16436137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients.
    Schneider LC; Rachid R; LeBovidge J; Blood E; Mittal M; Umetsu DT
    J Allergy Clin Immunol; 2013 Dec; 132(6):1368-74. PubMed ID: 24176117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K; Beder A; Beschorner J; Ahrens F; Gruebl A; Hamelmann E; Hansen G; Heinzmann A; Nemat K; Niggemann B; Wahn U; Beyer K
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basophil allergen threshold sensitivity and component-resolved diagnostics improve hazelnut allergy diagnosis.
    Brandström J; Nopp A; Johansson SG; Lilja G; Sundqvist AC; Borres MP; Nilsson C
    Clin Exp Allergy; 2015 Sep; 45(9):1412-8. PubMed ID: 25707509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of basophil allergen threshold sensitivity (CD-sens) to peanut and Ara h 8 in children IgE-sensitized to Ara h 8.
    Glaumann S; Nilsson C; Johansson SG; Asarnoj A; Wickman M; Borres MP; Nopp A
    Clin Mol Allergy; 2015; 13(1):5. PubMed ID: 25878561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.
    MacGlashan DW; Savage JH; Wood RA; Saini SS
    J Allergy Clin Immunol; 2012 Nov; 130(5):1130-1135.e5. PubMed ID: 22800400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible.
    Glaumann S; Nopp A; Johansson SG; Borres MP; Nilsson C
    PLoS One; 2013; 8(1):e53465. PubMed ID: 23326435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses.
    Grabenhenrich L; Lange L; Härtl M; Kalb B; Ziegert M; Finger A; Harandi N; Schlags R; Gappa M; Puzzo L; Stephan V; Heigele T; Büsing S; Ott H; Niggemann B; Beyer K
    J Allergy Clin Immunol; 2016 Jun; 137(6):1751-1760.e8. PubMed ID: 27087317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of component-resolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic.
    van Veen LN; Heron M; Batstra M; van Haard PMM; de Groot H
    BMC Pediatr; 2016 Jun; 16():74. PubMed ID: 27255511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophil allergen threshold sensitivity to casein (casein-specific CD-sens) predicts allergic reactions at a milk challenge in most but not all patients.
    Røisgård S; Nopp A; Lindam A; ; Nilsson CA; West CE
    Immun Inflamm Dis; 2024 May; 12(5):e1265. PubMed ID: 38722265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.